Douglas Jermasek - Nov 21, 2022 Form 4 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
EVP of Corporate Strategy
Signature
/s/ Doug Jermasek
Stock symbol
UNCY
Transactions as of
Nov 21, 2022
Transactions value $
$0
Form type
4
Date filed
11/23/2022, 07:00 AM
Previous filing
Nov 21, 2022
Next filing
Mar 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UNCY Stock Options Award $0 +55K +55% $0.00 155K Nov 21, 2022 Common Stock 55K $0.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 13,750 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.